Viewing Study NCT00674635

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:04 PM
Ignite Modification Date: 2026-05-21 @ 1:41 PM
Study NCT ID: NCT00674635
Status: COMPLETED
Last Update Posted: 2016-12-01
First Post: 2008-04-22
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase II Study Evaluating the Safety and Efficacy of GSK315234A in Patients With Rheumatoid Arthritis
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Arthritis, Rheumatoid View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adaptive study, View
None DAS28, View
None monoclonal antibody View
None GSK315234A; View
None rheumatoid arthritis, View